Perrigo | PRGO - Operating Profit


Perrigo reported $33.6M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
AbbVie USD 4.73B 1.08B Mar/2026
Abbott USD 1.85B 399M Mar/2026
Bayer EUR 3.53B 2.42B Mar/2026
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Coherus Biosciences USD -39.08M 3.65M Dec/2025
Corcept Therapeutics USD -49.6M 54.09M Mar/2026
Dr.Reddys Laboratories INR 888M 13.05B Mar/2026
Eli Lilly USD 9.78B 792M Mar/2026
J&J USD 6.62B 1.03B Mar/2026
Merck USD -1.88B 8.12B Mar/2026
Nestle CHF 6.84B 293M Dec/2025
Pacira USD 4.62M 1.43M Mar/2026
Perrigo USD 33.6M 50.8M Mar/2026
Pfizer USD 4.99B 340M Mar/2026
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Prestige Brands USD 75.49M 7M Mar/2026
Reckitt Benckiser GBP 747M 92M Dec/2024
Sanofi EUR 1.94B 239M Mar/2026
Supernus Pharmaceuticals USD -35.25M 49.07M Mar/2026
Teva Pharmaceutical Industries USD 758M 271M Mar/2026
Xeris Pharmaceuticals USD 16.77M 10.04M Dec/2025
Zoetis USD 865M 30M Mar/2026